These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

909 related articles for article (PubMed ID: 23026637)

  • 1. Fusion protein linkers: property, design and functionality.
    Chen X; Zaro JL; Shen WC
    Adv Drug Deliv Rev; 2013 Oct; 65(10):1357-69. PubMed ID: 23026637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design of the linkers which effectively separate domains of a bifunctional fusion protein.
    Arai R; Ueda H; Kitayama A; Kamiya N; Nagamune T
    Protein Eng; 2001 Aug; 14(8):529-32. PubMed ID: 11579220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of receptor binding on plasma half-life of bifunctional transferrin fusion proteins.
    Chen X; Lee HF; Zaro JL; Shen WC
    Mol Pharm; 2011 Apr; 8(2):457-65. PubMed ID: 21291258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The carboxyl-terminal region of human coagulation factor X as a natural linker for fusion strategies.
    Ferrarese M; Pignani S; Lombardi S; Balestra D; Bernardi F; Pinotti M; Branchini A
    Thromb Res; 2019 Jan; 173():4-11. PubMed ID: 30453126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design of helical linkers for fusion proteins and protein-based nanostructures.
    Arai R
    Methods Enzymol; 2021; 647():209-230. PubMed ID: 33482989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic fusion to albumin improves the pharmacokinetic properties of factor IX.
    Metzner HJ; Weimer T; Kronthaler U; Lang W; Schulte S
    Thromb Haemost; 2009 Oct; 102(4):634-44. PubMed ID: 19806248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increasing the homogeneity, stability and activity of human serum albumin and interferon-alpha2b fusion protein by linker engineering.
    Zhao HL; Yao XQ; Xue C; Wang Y; Xiong XH; Liu ZM
    Protein Expr Purif; 2008 Sep; 61(1):73-7. PubMed ID: 18541441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design of an in vivo cleavable disulfide linker in recombinant fusion proteins.
    Chen X; Bai Y; Zaro JL; Shen WC
    Biotechniques; 2010 Jul; 49(1):513-8. PubMed ID: 20615204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insertion of the designed helical linker led to increased expression of tf-based fusion proteins.
    Amet N; Lee HF; Shen WC
    Pharm Res; 2009 Mar; 26(3):523-8. PubMed ID: 19002568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of linker flexibility and length on the functionality of a cytotoxic engineered antibody fragment.
    Klement M; Liu C; Loo BL; Choo AB; Ow DS; Lee DY
    J Biotechnol; 2015 Apr; 199():90-7. PubMed ID: 25697559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design and characterization of structured protein linkers with differing flexibilities.
    Klein JS; Jiang S; Galimidi RP; Keeffe JR; Bjorkman PJ
    Protein Eng Des Sel; 2014 Oct; 27(10):325-30. PubMed ID: 25301959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improving the CH1-CK heterodimerization and pharmacokinetics of 4Dm2m, a novel potent CD4-antibody fusion protein against HIV-1.
    Chen W; Bardhi A; Feng Y; Wang Y; Qi Q; Li W; Zhu Z; Dyba MA; Ying T; Jiang S; Goldstein H; Dimitrov DS
    MAbs; 2016; 8(4):761-74. PubMed ID: 26963639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Construction of a linker library with widely controllable flexibility for fusion protein design.
    Li G; Huang Z; Zhang C; Dong BJ; Guo RH; Yue HW; Yan LT; Xing XH
    Appl Microbiol Biotechnol; 2016 Jan; 100(1):215-25. PubMed ID: 26394862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strategy for selecting and characterizing linker peptides for CBM9-tagged fusion proteins expressed in Escherichia coli.
    Kavoosi M; Creagh AL; Kilburn DG; Haynes CA
    Biotechnol Bioeng; 2007 Oct; 98(3):599-610. PubMed ID: 17394253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative understanding of the energy transfer between fluorescent proteins connected via flexible peptide linkers.
    Evers TH; van Dongen EM; Faesen AC; Meijer EW; Merkx M
    Biochemistry; 2006 Nov; 45(44):13183-92. PubMed ID: 17073440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conformations of variably linked chimeric proteins evaluated by synchrotron X-ray small-angle scattering.
    Arai R; Wriggers W; Nishikawa Y; Nagamune T; Fujisawa T
    Proteins; 2004 Dec; 57(4):829-38. PubMed ID: 15390267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of An Orally Effective Factor IX-Transferrin Fusion Protein for Hemophilia B.
    Xie C; Wang Z; Su Y; Wang J; Shen WC
    Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31861459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving the oral efficacy of recombinant granulocyte colony-stimulating factor and transferrin fusion protein by spacer optimization.
    Bai Y; Shen WC
    Pharm Res; 2006 Sep; 23(9):2116-21. PubMed ID: 16952003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficient production of single-chain Fv antibody possessing rare codon linkers in fed-batch fermentation.
    Kumada Y; Sakan Y; Kajihara H; Kihara M; Kikuchi Y; Yamaji H; Seong GH; Katoh S
    J Biosci Bioeng; 2009 Jan; 107(1):73-7. PubMed ID: 19147114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Linkers for improved cleavage of fusion proteins with an engineered alpha-lytic protease.
    Lien S; Milner SJ; Graham LD; Wallace JC; Francis GL
    Biotechnol Bioeng; 2001 Aug; 74(4):335-43. PubMed ID: 11410858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 46.